This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Korea Institute of Radiological & Medical Sciences. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Kee-Ho Lee: Innovator in Cancer Treatment
Introduction
Kee-Ho Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical science, particularly in the treatment of malignant tumors. His innovative work focuses on utilizing genetic components to enhance cancer therapies.
Latest Patents
Kee-Ho Lee holds a patent for a pharmaceutical composition aimed at treating malignant tumors. This composition includes a human p31 gene encoding protein, which has been shown to suppress cancer cell growth, induce apoptosis, and effectively kill cells by overexpressing p31 in solid malignant tumor cells. This groundbreaking approach offers promising avenues for gene therapy in oncology.
Career Highlights
Kee-Ho Lee is affiliated with the Korea Institute of Radiological and Medical Sciences, where he conducts research and develops innovative treatments for cancer. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Collaborations
Kee-Ho Lee collaborates with esteemed colleagues such as Sang-Hoon Kim and Hyun-Jung Baek. Their combined expertise contributes to the development of effective cancer treatments and enhances the research capabilities of their institution.
Conclusion
Kee-Ho Lee's contributions to cancer treatment through innovative pharmaceutical compositions highlight the potential of gene therapy in modern medicine. His work continues to inspire advancements in the fight against malignant tumors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile